Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy

Disease Markers

Volumn 30, Issue 4, 2011, Pages 171-179

  Wang, Gang ^a,b   Kwan, Bonnie Ching Ha ^a   Lai, Fernand Mac Moune ^a   Chow, Kai Ming ^a   Li, Philip Kam Tao ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

chronic renal failure; microRNA; proteinuria

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA; MICRORNA 146A; MICRORNA 155; RANTES; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS; URINE SEDIMENT;

EID: 79959761647     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0766     Document Type: Article

References (36)

1. J.V. Donadio and J.P. Grande, IgA nephropathy, N Engl J Med 347 (2002), 738-748. (Pubitemid 35203906)
2. F.C. Berthoux, H. Mohey and A. Afiani, Natural history of primary IgA nephropathy, Semin Nephrol 28 (2008), 4-9.
3. C.H. Tan, P.T. Loh,W.S.Yang andC.M. Chan, Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review, Singapore Med J 49 (2008), 780-785.
4. M.E. Lammand S.N. Emancipator, The mucosal immune system and IgA nephropathy, Semin Nephrol 7 (1987), 280-282.
5. F.B. Waldo, Systemic immune response after mucosal immunization in patients with IgA nephropathy, J Clin Immunol 12 (1992), 21-26.
6. S.N. Emancipator, Immunoregulatory factors in the pathogenesis of IgA nephropathy, Kidney Int 38 (1990), 1216-1229.
7. J. Feehally and A. Allen, Abnormalities of IgA1 production in IgA nephropathy, Nephrology 7 (2002), S100-S105.
8. W.P. Kloosterman and R.H. Plasterk, The diverse functions of microRNAs in animal development and disease, Dev Cell 11 (2006), 441-450. (Pubitemid 44430905)
9. K.M. Pauley, S. Cha and E.K. Chan, MicroRNA in autoimmunity and autoimmune diseases, J Autoimmun 32 (2009), 189-194.
10. K.M. Pauley and E.K. Chan, MicroRNAs and their emerging roles in immunology, AnnNYAcad Sci 1143 (2008), 226-239.
11. Y. Bi, G. Liu and R. Yang, MicroRNAs: novel regulators during the immune response, J Cell Physiol 218 (2009), 467-472.
12. A.E. Williams, M.M. Perry, S.A. Moschos, H.M. Larner- Svensson and M.A. Lindsay, Role of miRNA-146a in the regulation of the innate immune response and cancer, Biochem Soc Trans 36 (2008), 1211-1215.
13. I. Faraoni, F.R. Antonetti, J. Cardone and E. Bonmassar, miR- 155 gene: a typical multifunctional microRNA, Biochim Biophys Acta 1792 (2009), 497-505.
14. Y. Dai, W. Sui, H. Lan, Q. Yan, H. Huang and Y. Huang, Microarray analysis of micro-ribonucleic acid expression in primary immunoglobulin A nephropathy, Saudi Med J 29 (2008), 1388-1393.
15. W. Gang, B.C. Kwan, F.M. Lai, P.C. Choi, K.M. Chow, P.K. Li and C.C. Szeto, Intra-renal expression of microRNAs in patients with IgA nephropathy, Lab Invest 90 (2010), 98-103.
16. G.Wang, B.C. Kwan, F.M. Lai, K.M. Chow, P.K. Li and C.C. Szeto, Expression of microRNAs in the urinary sediment of patients with IgA nephropathy, Dis Marker 28 (2010), 79-86.
17. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers and D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med 130 (1999), 461-470. (Pubitemid 29135798)
18. W. Mitch, Measuring the rate of progression of renal insufficiency, in: WE M, J S, BM B, ed., The Progressive Nature of Renal Disease, New York: Churchill Livingstone Inc (1986), pp. 203-320.
19. S. Bhandari, N. Watson, E. Long, S. Sharpe, W. Zhong, S.Z. Xu and S.L. Atkin, Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney, J Histochem Cytochem 56 (2008), 733-743. (Pubitemid 351991086)
20. A. Biosystems, Endogenous Controls for Real-Time Quantitation of miRNA Using TaqMan® MicroRNA Assays, Application Note TaqMan® MicroRNA Assays (2007).
21. D.R. Helsel, Less than obvious - statistical treatment of data below the detection limit, Environ Sci Technol 24 (1990), 1766-1774.
22. M. Kato, L. Arce and R. Natarajan, MicroRNAs and their role in progressive kidney diseases, Clin J Am Soc Nephrol 4 (2009), 1255-1266.
23. S. Saal and S.J. Harvey, MicroRNAs and the kidney: coming of age, Curr Opin Nephrol Hypertens 18 (2009), 317-323.
24. S.O. Lee, T. Masyuk, P. Splinter, J.M. Banales, A. Masyuk, A. Stroope and N. Larusso,MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease, J Clin Invest 118 (2008), 3714-3724.
25. H. Sun, Q.W. Li, X.Y. Lv, J.Z. Ai, Q.T. Yang, J.J. Duan, G.H. Bian, Y. Xiao, Y.D. Wang, Z. Zhang, Y.H. Liu, R.Z. Tan, Y. Yang, Y.Q. Wei and Q. Zhou, MicroRNA-17 posttranscriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation, Mol Biol Rep (2009), Oct 10.
26. Z. Zhang, H. Peng, J. Chen, X. Chen, F. Han, X. Xu, X. He and N. Yan, MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice, FEBS Lett 583 (2009), 2009-2014.
27. M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, J.J. Rossi andR.Natarajan, MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors, Proc Natl Acad Sci U S A 104 (2007), 3432-3437. (Pubitemid 46364176)
28. Q. Wang, Y. Wang, A.W. Minto, J. Wang, Q. Shi, X. Li and R.J. Quigg, MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy, FASEB J 22 (2008), 4126-4135.
29. M. Kato, S. Putta, M. Wang, H. Yuan, L. Lanting, I. Nair, A. Gunn, Y. Nakagawa, H. Shimano, I. Todorov, J.J. Rossi and R. Natarajan, TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN, Nat Cell Biol 11 (2009), 881-889.
30. Y. Liang, D. Ridzon, L. Wong and C. Chen, Characterization of microRNA expression profiles in normal human tissues, BMC Genomics 8 (2007), 166.
31. J. Hou, P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang and X. Cao, MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2, J Immunol 183 (2009), 2150-2158.
32. M. Ceppi, P.M. Pereira, I. Dunand-Sauthier, E. Barras,W. Reith, M.A. Santos and P. Pierre, MicroRNA-155 modulates the interleukin-1 signaling pathway in activated humanmonocytederived dendritic cells, Proc Natl Acad Sci U S A 106 (2009), 2735-2740.
33. M.M. Perry, S.A. Moschos, A.E. Williams, N.J. Shepherd, H.M. Larner-Svensson and M.A. Lindsay, Rapid changes in microRNA-146a expression negatively regulate the IL-1betainduced inflammatory response in human lung alveolar epithelial cells, J Immunol 180 (2008), 5689-5698.
34. H. Huang, Y. Peng, F. Liu and H. Lei, Is IgA nephropathy induced by abnormalities of CD4+CD25+Treg cells in the tonsils? Med Hypotheses 69 (2007), 410-413. (Pubitemid 46818703)
35. Y. Zheng, S.Z. Josefowicz, A.Kas, T.T. Chu, M.A. Gavin and A.Y. Rudensky, Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells, Nature 445 (2007), 936-940.
36. S. Kohlhaas, O.A. Garden, C. Scudamore, M. Turner, K. Okkenhaug and E. Vigorito, Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J Immunol 182 (2009), 2578-2582.